Biotechnology
DiaMedica Therapeutics Rises After Nasdaq Listing Announcement
Most cannabis penny stocks are down today on the TSXV. In 2018, cannabis companies took over the TSX Venture Exchange. Last year, it was blockchain companies that dominated. However, a biotherapeutics company by the name ... [Read]
Biotechnology
PPCB Stock Up More than 30% After Partnering with LaVoieHealthScience
It’s always exciting when small-cap companies make it as a Yahoo Finance trending ticker. Today, December 19th, the PPCB stock made it. Propanc Biopharma (OTCQB:PPCB) has a current market cap of $11.488 million. On Wednesday, ... [Read]
Biotechnology
GTx Inc Recovers Slightly on the Market Today After a Disastrous September
GTx Inc. (NASDAQ:GTXI) is a biopharmaceutical company that is headquartered in Memphis, Tennessee, and was founded in 1997. The company focuses on discovering and developing medicines in the treatment of stress urinary incontinence (SUI) and ... [Read]
Biotechnology
ProQR Therapeutics Jumps 60% on Favorable Clinical News
Every day, biotech companies are fighting to make the world a better, healthier, and safer place, and if releasing favorable clinical trial news makes shares jump, then that’s a bonus. Today, this happened after results ... [Read]
Biotechnology
Bellerophon Stock Plunges 68% After Committee Terminates INOpulse Study
The biotechnology industry can be a tough one. When trials are a success, a company’s stock flies. However, the opposite can occur when trials get rejected. On Tuesday, the latter happened to Bellerophon Therapeutics. After ... [Read]
Biotechnology
Progenics Pharmaceuticals’ Stock Gets an 8% Boost After FDA Approval
Progenics Pharmaceuticals receives FDA approval for the first drug to treat rare and extremely life-threatening cancers in patients 12 and older. This approval has boosted the company’s stock exponentially on today’s market. Progenics Pharmaceuticals Receives FDA ... [Read]
Biotechnology
Tonix Pharmaceuticals Holding Corp Falls Nearly 70% Today
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced this morning that it would be halting its Phase 3 study of its Tonmya drug, which caused its stock price to drop in dramatic fashion. After its twelve-week trial, ... [Read]
Biotechnology
resTORbio Inc’s Positive Phase 2b Trial Results Boost Stock 50%
Shares of resTORbio Inc (NASDAQ:TORC) jumped today after the company announced via press release the results of its phase 2 clinical study. The small biotech company has the drug RTB101, which is used to treat ... [Read]
Biotechnology
FDA Waives BioPharmX Corporation’s Study and Stock Jumps 16%
FDA waives BioPharmX study, in what many would consider a huge break for the company. FDA Waives BioPharmX Study The Palo Alto-based specialty pharmaceutical company that develops products for dermatologists announced via press release early ... [Read]
Biotechnology
FDA: CTI BioPharma Must Conduct A Third Pacritinib Phase 3 Study
Today, the FDA requested a third CTI BioPharma Pacritinib phase 3 study. Usually, getting approval from the FDA to start a phase 3 clinical trial on a drug is a good thing. It’s not a good thing, ... [Read]